NUWE is racing to raise capital before its cash runs out (Q2 2026). The best-efforts structure with no minimum means the offering might close with far less than $4.4M. Massive dilution from the standalone offering plus the existing overhang of 4.8M warrants likely caps any rally. Watch for whether the warrants are priced with an exercise price far above market, making them near worthless to investors. The stock is a distressed micro-cap with delisting risk — short interest or avoidance warranted.
Executive Summary
Nuwellis, Inc. filed an S-1 registration statement for a best-efforts standby equity offering of up to 4,854,369 shares of common stock, pre-funded warrants, and warrants to raise approximately $5M at $1.03/share. The company has a $3M market cap, near-zero analyst bullishness, a history of operating losses (net loss of $17.5M in FY2025, accumulated deficit of $316.3M), and only enough cash to fund operations through Q2 2026. The offering is a dilutive emergency capital raise with no minimum and a termination date of June 30, 2026, and will further pressure the stock.
Key Facts
- Up to 4,854,369 shares offered at assumed $1.03/share plus Series C/D warrants; no minimum offering requirement
- Estimated net proceeds of ~$4.4M if fully sold; only $2.1M cash on hand as of March 31, 2026
- Net loss of $17.5M in FY2025; accumulated deficit of $316.3M; going concern risk flagged by auditor (Baker Tilly)
- Two material weaknesses in internal controls over financial reporting
- Stock fell below $1.00 bid price in June 2025; only regained compliance via reverse split; Nasdaq proposed $5M market value listing rule could prompt delisting
- Massive overhang: 4.8M warrants outstanding at weighted avg exercise price of $5.18 (far above current price of $1.03)
- Warrants included in offering have placeholder exercise price; exercisability contingent on stockholder approval unless pricing conditions met
- Ladenburg Thalmann acting as placement agent for 8% cash fee plus 3% warrant coverage
Financial Impact
Up to $5M gross raised; net ~$4.4M with only $2.1M cash on hand. Immediate dilution: 4.85M shares vs 2.64M outstanding (184% dilution). Offering has no minimum, so proceeds could be far lower.
Risk Factors
- Best-efforts offering may fail to raise sufficient capital, forcing a restructuring or bankruptcy
- Nasdaq delisting risk: proposed $5M market value rule and continued bid price risk after multiple reverse splits
- Massive dilution: 4.85M new shares + 9.7M warrant shares + 4.8M existing warrants vs 2.64M shares outstanding
- Going-concern opinion in auditor report; only $2.1M cash to fund operations
- Two material weaknesses in internal controls; risk of further restatements or delays
- Single-product dependency (Aquadex System) with limited market adoption and no direct competitors other than diuretics
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1 Filing (Primary) | 0001140361-26-022629 |
| Document: ny20073226x1_ex107.htm | 0001140361-26-022629 |
| Document: ny20073226x1_ex5-1.htm | 0001140361-26-022629 |
| Document: ny20073226x1_ex23-1.htm | 0001140361-26-022629 |
| Document: 0001140361-26-022629-index-headers.html | 0001140361-26-022629 |
| Document: 0001140361-26-022629-index.html | 0001140361-26-022629 |
| Document: 0001140361-26-022629.txt | 0001140361-26-022629 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 8-K | $0.3221 | awaiting T+20 | — | $5.41 (+1579.60%) |
Sep 18, 2026 5w ago | SC 13G/A | $0.8700 $0.5600 | ▼ −35.63% | ▼ −34.72% | $5.41 (+521.84%) |
Sep 17, 2026 5w ago | Press Release | $1.09 $0.5532 | ▲ +49.25% | ▲ +50.45% | $5.41 (−396.33%) |
Aug 27, 2026 8w ago | EFFECT | $0.9900 $0.7915 | ▲ +20.05% | ▲ +19.95% | $5.41 (−446.46%) |
Aug 25, 2026 8w ago | 8-K | $1.01 $0.8700 | ▼ −13.86% | ▼ −15.06% | $5.41 (+435.64%) |
Aug 13, 2026 10w ago | Press Release | $1.30 $0.7740 | ▲ +40.46% | ▲ +38.71% | $5.41 (−316.15%) |
Aug 3, 2026 12w ago | 424B5 | $14.49 $7.13 | ▲ +50.78% | ▲ +52.01% | $5.41 (+62.66%) |
Jul 31, 2026 12w ago | Press Release | $1.74 $0.8889 | ▲ +48.91% | ▲ +51.90% | $5.41 (−210.92%) |
Jun 16, 2026 19w ago | Press Release | $0.1350 $0.0840 | ▼ −37.78% | ▼ −37.83% | $5.41 (+3907.41%) |
Jun 10, 2026 19w ago | 8-K | $0.1520 $0.0869 | ▲ +42.86% | ▲ +46.93% | $5.41 (−3459.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers